DR-5/DR-4 cross reactive mAbs (Crystal Bioscience)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameDR-5/DR-4 cross reactive mAbs (Crystal Bioscience)
Drug Alias Namedeath receptor -5/4 cross reactive mAbs (Crystal Bioscience)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTumor necrosis factor receptor superfamily member 10B modulatorsTumor necrosis factor receptor superfamily member 10A modulators
TargetsTumor necrosis factor receptor superfamily member 10BTumor necrosis factor receptor superfamily member 10A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCrystal Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrystal Bioscience Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A